» Articles » PMID: 12358273

Obese Children with Steatohepatitis Can Develop Cirrhosis in Childhood

Overview
Specialty Gastroenterology
Date 2002 Oct 3
PMID 12358273
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic steatohepatitis, in which fatty change and inflammation of the liver occur in the absence of excess alcohol intake, is increasingly recognized in obese children. Although fibrosis is common in pediatric nonalcoholic steatohepatitis, cirrhosis has been reported rarely. The two boys reported here developed cirrhosis from nonalcoholic steatohepatitis at ages 10 and 14 yr. One child progressed to cirrhosis with symptomatic portal hypertension within a 2-yr period.

Citing Articles

Pediatric MASLD: current understanding and practical approach.

Stroes A, Vos M, Benninga M, Koot B Eur J Pediatr. 2024; 184(1):29.

PMID: 39560782 DOI: 10.1007/s00431-024-05848-1.


KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.

Kim M, Han J, An J, Kim B, Jin Y, Kim S Clin Mol Hepatol. 2024; 30(Suppl):S5-S105.

PMID: 39159947 PMC: 11493350. DOI: 10.3350/cmh.2024.0506.


Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis.

Joo J, Yoo I, Yang H Pediatr Gastroenterol Hepatol Nutr. 2024; 27(4):236-245.

PMID: 39035406 PMC: 11254650. DOI: 10.5223/pghn.2024.27.4.236.


The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD.

Conroy C, Radulescu A, Attia S, Shelman N, Lee J, Monticelli R Saudi J Gastroenterol. 2024; 30(4):252-259.

PMID: 38726916 PMC: 11379251. DOI: 10.4103/sjg.sjg_428_23.


Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis.

Foo R, Ma J, Du R, Goh G, Chong Y, Zhang C EClinicalMedicine. 2024; 72:102609.

PMID: 38707911 PMC: 11067479. DOI: 10.1016/j.eclinm.2024.102609.